VCEL(Vericel Corporation) · 财务报表

VCEL(Vericel Corporation) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$156.18M$164.37M$197.52M$237.22M$276.26M
毛利润$106.03M$109.79M$135.58M$172.11M$205.60M
营业利润−$7.85M−$17.06M−$6.46M$4.52M$11.04M
净利润−$7.47M−$16.71M−$3.18M$10.36M$16.52M
经营现金流$29.04M$17.69M$35.31M$58.16M$51.91M
自由现金流$21.12M$10.09M$15.30M−$5.81M$24.75M
摊薄每股收益$-0.16$-0.35$-0.07$0.20$0.32

Vericel Corporation VCEL